Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 27 Apr 22 424B5 Prospectus supplement for primary offering
- 26 Apr 22 424B5 Prospectus supplement for primary offering
- 11 Mar 22 EFFECT Notice of effectiveness
- 8 Feb 22 POS AM Prospectus update (post-effective amendment)
- 8 Feb 22 POSASR Automatic shelf registration (post-effective amendment)
- 4 Aug 20 424B5 Prospectus supplement for primary offering
- 14 Feb 20 424B5 Prospectus supplement for primary offering
- 12 Feb 20 424B5 Prospectus supplement for primary offering
-
12 Feb 20 S-3ASR Automatic shelf registration
DCPH similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 of Deciphera Pharmaceuticals, Inc.of our report dated March 14, 2019 relating to the financial statements, which appears in Deciphera Pharmaceuticals, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2018. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 12, 2020